Mouse CD8+ T Cell Enrichment Column, Small, Pack of 4

• Supplier: R&D Systems
• Catalog: MCD8C-1000
• Prices: $299.00
• Sizes: 1 kit (4 Columns)
• Species Reactivities: Mouse
• Gene: CD8A

Product References

Both rejection and tolerance of allografts can occur in the absence of secondary - Both rejection and tolerance of allografts can occur in the absence of secondary

Kant CD, Akiyama Y, Tanaka K, Shea S, Yamada Y, Connolly SE, Marino J, Tocco G, Benichou G. J Immunol. 2015 Feb 1;194(3):1364-71.

CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in - CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in

Villarroel VA, Okiyama N, Tsuji G, Linton JT, Katz SI. J Invest Dermatol. 2014 Jun;134(6):1552-60.

Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. - Oxidized lipids block antigen cross-presentation by dendritic cells in cancer.

Ramakrishnan R, Tyurin VA, Veglia F, Condamine T, Amoscato A, Mohammadyani D, Johnson JJ, Zhang LM, Klein-Seetharaman J, Celis E, Kagan VE, Gabrilovich DI. J Immunol. 2014 Mar 15;192(6):2920-31.

Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by - Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by

Okiyama N, Furumoto Y, Villarroel VA, Linton JT, Tsai WL, Gutermuth J, Ghoreschi K, Gadina M, O'Shea JJ, Katz SI. J Invest Dermatol. 2014 Apr;134(4):992-1000.

An artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the - An artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the

Steenblock ER, Fadel T, Labowsky M, Pober JS, Fahmy TM. J Biol Chem. 2011 Oct 7;286(40):34883-92.

Reversion of immune tolerance in advanced malignancy: modulation of - Reversion of immune tolerance in advanced malignancy: modulation of

Pan PY, Wang GX, Yin B, Ozao J, Ku T, Divino CM, Chen SH. Blood. 2008 Jan 1;111(1):219-28. Epub 2007 Sep 20.